Affiliation:
1. 1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece
2. Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK
3. 3rd Cardiology Department, Sotiria Regional Hospital for Chest Diseases, University of Athens Medical School, Athens, Greece
Abstract
Abstract:
As atherosclerosis remains a leading cause of morbidity and mortality worldwide despite the advances in its medical and interventional management, the identification of markers associated with its incidence and prognosis constitutes an appealing prospect. In this regard, asymmetric dime-thylarginine (ADMA), a well-studied endogenous endothelial nitric oxide synthase inhibitor, repre-sents a core mediator of endothelial dysfunction in atherosclerotic diseases. Given the pathophysio-logic background of this molecule, its importance in the most frequent atherosclerotic manifesta-tion, coronary artery disease (CAD), has been extensively studied in the past decades. The available evidence suggests elevation of ADMA in the presence of common cardiovascular risk factors, namely diabetes mellitus, arterial hypertension, and hypertriglyceridemia, being related to endothe-lial dysfunction and incident major adverse cardiovascular events in these groups of patients. More-over, ADMA is associated with CAD occurrence and severity, as well as its prognosis, especially in populations with renal impairment. Interestingly, even in the absence of obstructive CAD, increased ADMA may indicate coronary endothelial dysfunction and epicardial vasomotor dysfunction, which are prognostication markers for incident cardiovascular events. In the case of acute coronary syn-dromes, high ADMA levels signify an augmented risk of incomplete ST-segment elevation resolu-tion and poorer prognosis. Abnormal ADMA elevations may indicate adverse outcomes following percutaneous or surgical coronary revascularization, such as in-stent restenosis, graft patency, and hard cardiovascular endpoints. Finally, since its association with inflammation is significant, chron-ic inflammatory conditions may present with coronary endothelial dysfunction and subclinical cor-onary atherosclerosis by means of increased coronary artery calcium, with augmented ADMA act-ing as a biomarker.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献